BioPharma ABVC Gains 280 Support Holds at 104 20260519 Mexco MXC Stock Today Rallies 143 Resistance at 1007 20260515 Theriva Biologics TOVX Stock Jumps 137 Approaching 030 20260518 Ranpak Holdings PACK Reports Strong Q1 2026 Revenue NA EPS Beats SK Hynix Shatters Profit Records as AI Chip Demand Fuels Memory Boom Global Leaders Watch TrumpXi Summit for Trade Signals Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday USIran Standoff Deepens as Trump Rejects Peace Counteroffer Threatening Global Energy Supplies MegaIPOs Could Signal Market Top as SpaceX and OpenAI Prep Record Floats The Mandalorian and Grogu Posts Lowest Star Wars Opening for Disney with 82M Debut NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Operational Discipline DUK Q1 2026 Earnings EPS Surpasses Estimates as Duke Energy Delivers Steady Operations MPLT Q1 2026 Earnings WiderthanExpected Loss Reflects Continued Development Spending SKIN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 421 Power REIT PW Q2 2025 Earnings Reports Positive EPS Amid Limited Disclosure Neonode Inc NEON Q1 2026 Earnings EPS Misses Estimates by Nearly 8 Art Technology Acquisition Corp ARTC Holds Near Key Levels with Minimal Price Movement PS International Group PSIG Surges 183 as Stock Tests Key Resistance Level at 82 Ryanair Holdings RYAAY Edges Lower Consolidation Phase Near 6086 Amid Ongoing Sector Headwinds Duluth Holdings DLTH Jumps 43 as Stock Tests Critical Resistance Zone OFS Credit Company Inc OCCI Edges Higher Navigating Support and Resistance Levels Trump Organization Tbilisi Project Raises ConflictofInterest Concerns Over Sanctioned Ties ADAML Q1 2026 Earnings Significant EPS Beat as Preferred Stock Delivers Strong Performance CVD Equipment Corporation CVV Surges Over 4 Key Levels to Watch Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts ADAM Q1 2026 Earnings Strong EPS Beat Drives Optimism CCCC Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction GTIM Q1 2026 Earnings Modest Profitability Amid Operational Challenges Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines ePlus inc PLUS Q1 2026 Earnings EPS Surges 4075 Above Estimates Stock Rises LW Q1 2026 Earnings EPS Surpasses Estimates Amid Resilient Demand